Aptahem AB (publ)
Stockholm Stock Exchange APTA.ST
Aptahem AB (publ) Goodwill for the year ending December 31, 2023
Aptahem AB (publ) Goodwill is NA for the year ending December 31, 2023. Goodwill is the value attributed to intangible assets, such as brand reputation or customer relationships, acquired in a business combination.
Key data
| Date | Goodwill | Total Assets | Current Liabilities | Total Non-Current Liabilities |
|---|
Market news
Loading...
Stockholm Stock Exchange: APTA.ST
| CEO | Mr. Mikael Lindstam |
| IPO Date | April 17, 2015 |
| Location | Sweden |
| Headquarters | Norra Vallgatan 58, 4TR |
| Employees | 5 |
| Sector | Health Care |
| Industries | |
Description
Aptahem AB (publ), a clinical stage biotechnology company, develops aptamer-based pharmaceuticals for the treatment of acute life-threatening conditions. Its principal pharmaceutical candidate is Apta-1, which is in preclinical stage to prevent mortality rate caused by organ and tissue damage in sepsis patients. The company has collaborations with various academic groups, including Consortium with Orebro University, Seattle Children's Research Institute, and University Health Network. Aptahem AB (publ) was incorporated in 2014 and is based in Malmö, Sweden.
Key trends
Past 5 years
StockViz Staff
January 15, 2025
Any question? Send us an email